Display options
Cite
Borzio M, Dionigi E, Parisi G, et al. Management of hepatocellular carcinoma in the elderly. World J Hepatol. 2015;7(11):1521-9doi: 10.4254/wjh.v7.i11.1521.
Borzio, M., Dionigi, E., Parisi, G., Raguzzi, I., & Sacco, R. (2015). Management of hepatocellular carcinoma in the elderly. World journal of hepatology, 7(11), 1521-9. https://doi.org/10.4254/wjh.v7.i11.1521
Borzio, Mauro, et al. "Management of hepatocellular carcinoma in the elderly." World journal of hepatology vol. 7,11 (2015): 1521-9. doi: https://doi.org/10.4254/wjh.v7.i11.1521
Borzio M, Dionigi E, Parisi G, Raguzzi I, Sacco R. Management of hepatocellular carcinoma in the elderly. World J Hepatol. 2015 Jun 18;7(11):1521-9. doi: 10.4254/wjh.v7.i11.1521. PMID: 26085911; PMCID: PMC4462690.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2015 Jun 18;7(11):1521-9. doi: 10.4254/wjh.v7.i11.1521.

Management of hepatocellular carcinoma in the elderly.

World journal of hepatology

Mauro Borzio, Elena Dionigi, Giancarlo Parisi, Ivana Raguzzi, Rodolfo Sacco

Affiliations

  1. Mauro Borzio, Elena Dionigi, Ivana Raguzzi, Unità di Gastroenterologia, Azienda Ospedaliera di Melegnano, 20070 Vizzolo Predabissi, Italy.

PMID: 26085911 PMCID: PMC4462690 DOI: 10.4254/wjh.v7.i11.1521

Abstract

Mean age of hepatocellular carcinoma (HCC) patients has been progressively increasing over the last decades and ageing of these patients is becoming a real challenge in every day clinical practice. Unfortunately, international guidelines on HCC management do not address this problem exhaustively and do not provide any specific recommendation. We carried out a literature search in MEDLINE database for studies reporting on epidemiology, clinical characteristics and treatment outcome of HCC in elderly patients. Available data seem to indicate that in elderly patients the outcome of HCC is mostly influenced by liver function and tumor stage rather than by age and the latter should not influence treatment allocation. Age is not a risk for resection and older patients with resectable HCC and good liver function could gain benefit from surgery. Mild comorbidities do not seem a contraindication for surgery in aged patients. Conversely, major resection in elderly, even when performed in experienced high-volume centres, should be avoided. Both percutaneous ablation and transarterial chemoembolization are not contraindicated in aged patients and safety profile of these procedures is acceptable. Sorafenib is a viable option for advanced HCC in elderly provided that a careful evaluation of concomitant comorbidities, particularly cardiovascular ones, is taken into account. Available data seem to suggest that in either elderly and younger, treatment is a main predictor of outcome. Consequently, a nihilistic attitude of physicians towards under- or no-treatment of aged patients should not be longer justified.

Keywords: Cirrhosis; Elderly; Epidemiology; Hepatocarcinoma; Treatment

References

  1. Hepatology. 2011 Mar;53(3):1020-2 - PubMed
  2. Semin Liver Dis. 1999;19(3):329-38 - PubMed
  3. Oncology. 2013;84(5):265-72 - PubMed
  4. J Surg Oncol. 2009 Mar 1;99(3):154-60 - PubMed
  5. Oncol Lett. 2011 Sep 1;2(5):851-854 - PubMed
  6. J Korean Med Sci. 2012 Oct;27(10):1147-54 - PubMed
  7. World J Surg. 2008 Oct;32(10):2223-9 - PubMed
  8. J Am Coll Surg. 2011 May;212(5):787-95 - PubMed
  9. J Am Geriatr Soc. 2011 Feb;59(2):241-50 - PubMed
  10. J Clin Gastroenterol. 2012 Jan;46(1):62-70 - PubMed
  11. Lancet. 1998 Jan 17;351(9097):214-5 - PubMed
  12. Cancer. 2005 Mar 15;103(6):1201-9 - PubMed
  13. Med Oncol. 2013 Mar;30(1):446 - PubMed
  14. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):342-7 - PubMed
  15. Eur J Gastroenterol Hepatol. 2013 Aug;25(8):912-9 - PubMed
  16. Cancer. 2009 Dec 1;115(23):5507-15 - PubMed
  17. Am J Gastroenterol. 1999 Sep;94(9):2460-6 - PubMed
  18. World J Surg. 2009 Sep;33(9):1927-32 - PubMed
  19. J Gastroenterol. 2012 Oct;47(10):1125-33 - PubMed
  20. Cancer. 2010 Apr 1;116(7):1733-8 - PubMed
  21. Sci Am. 1993 Apr;268(4):46-52 - PubMed
  22. J Gastroenterol Hepatol. 2004 Aug;19(8):859-65 - PubMed
  23. Hepatology. 2010 Jun;51(6):1972-8 - PubMed
  24. J Gastrointest Surg. 2009 Sep;13(9):1627-35 - PubMed
  25. N Engl J Med. 2008 Jul 24;359(4):378-90 - PubMed
  26. Hepatology. 2010 Aug;52(2):518-27 - PubMed
  27. Hepatol Res. 2010 Oct;40(10):997-1005 - PubMed
  28. Arch Surg. 2003 May;138(5):547-52 - PubMed
  29. Hepatogastroenterology. 2004 Jan-Feb;51(55):219-23 - PubMed
  30. Expert Rev Anticancer Ther. 2013 Dec;13(12):1355-61 - PubMed
  31. Arch Surg. 1994 Aug;129(8):846-50 - PubMed
  32. Hepatol Res. 2008 Jan;38(1):37-51 - PubMed
  33. J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):389-93 - PubMed
  34. Lancet. 1990 Apr 28;335(8696):1020-2 - PubMed
  35. Hepatol Int. 2012 Jan;6(1):403-7 - PubMed
  36. J Hepatol. 1998 Dec;29(6):944-52 - PubMed
  37. J Clin Oncol. 2007 May 10;25(14):1936-44 - PubMed
  38. Nat Rev Gastroenterol Hepatol. 2014 May;11(5):273-4 - PubMed
  39. N Engl J Med. 1999 Dec 30;341(27):2061-7 - PubMed
  40. Br J Cancer. 1994 Oct;70(4):690-3 - PubMed
  41. Dig Dis Sci. 2015 May;60(5):1465-73 - PubMed
  42. Hepatol Res. 2014 Dec;44(13):1329-38 - PubMed
  43. Lancet Oncol. 2009 Jan;10(1):25-34 - PubMed
  44. J Clin Oncol. 2006 Jan 1;24(1):141-4 - PubMed
  45. Eur J Surg Oncol. 2006 Sep;32(7):767-72 - PubMed
  46. Hepatology. 2003 May;37(5):1202-19 - PubMed
  47. Crit Rev Oncol Hematol. 2006 Sep;59(3):243-9 - PubMed
  48. Arch Surg. 2012 Feb;147(2):137-44 - PubMed
  49. J Gastrointest Surg. 2009 Apr;13(4):695-701 - PubMed
  50. Hepatology. 2013 Jan;57(1):112-9 - PubMed
  51. Liver Int. 2014 Aug;34(7):1109-17 - PubMed
  52. J Hepatol. 2013 Oct;59(4):753-61 - PubMed
  53. Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578 - PubMed
  54. J Hepatol. 2012 Feb;56(2):397-405 - PubMed
  55. J Gastroenterol Hepatol. 2007 Aug;22(8):1226-31 - PubMed
  56. Gastroenterology. 2004 Apr;126(4):1005-14 - PubMed
  57. Hepatol Int. 2010 Mar 18;4(2):439-74 - PubMed
  58. J Gerontol. 1976 Jul;31(4):441-7 - PubMed
  59. J Clin Gastroenterol. 2013 Apr;47(4):359-66 - PubMed
  60. Hepatol Res. 2012 Aug;42(8):767-73 - PubMed
  61. Jpn J Clin Oncol. 2011 Dec;41(12):1358-65 - PubMed
  62. J Gastrointestin Liver Dis. 2012 Dec;21(4):397-405 - PubMed
  63. Oncologist. 2011;16(12):1721-8 - PubMed
  64. J Am Coll Surg. 2010 Apr;210(4):441-8 - PubMed
  65. Future Oncol. 2013 Feb;9(2):283-94 - PubMed
  66. World J Gastroenterol. 2013 Apr 28;19(16):2521-8 - PubMed
  67. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7 - PubMed
  68. Hepatology. 2005 Nov;42(5):1208-36 - PubMed
  69. Hepatology. 2006 Dec;44(6):1543-54 - PubMed
  70. Cancer Causes Control. 2000 Jan;11(1):31-5 - PubMed
  71. Gut. 2010 Mar;59(3):387-96 - PubMed
  72. J Hepatol. 2012 Apr;56(4):908-43 - PubMed
  73. Surgery. 2010 May;147(5):696-703 - PubMed

Publication Types